Company Profile

Company Description

Akero Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing transformative treatments for serious metabolic diseases, particularly nonalcoholic steatohepatitis (NASH). Their pipeline includes innovative therapies designed to address liver fibrosis and inflammation. By leveraging cutting-edge research, the company aims to improve patient outcomes in areas with significant unmet medical needs. Their lead candidate has shown promise in clinical trials, offering potential breakthroughs for chronic liver conditions. The firm collaborates with leading researchers and institutions to advance its mission of delivering effective, life-changing therapies.